Acute effects of intravenous infusion of apoA1/phosphatidylcholine discs on plasma lipoproteins in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 979-989

  Nanjee, M N ^a   Doran, J E ^b   Lerch, P G ^b   Miller, Norman E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Central Laboratory in Bern   (Switzerland)

Author keywords

Apolipoprotein A1; Cholesterol; HDLs; Lecithin; Phosphatidylcholine

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; ESTERIFICATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOELECTROPHORESIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032921161     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.979     Document Type: Article

References (58)

1. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 1984;25: 1017-1058.
2. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry. 1988;27: 25-29.
3. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
4. Stein O, Vanderhoek J, Stein Y. Cholesterol content and sterol synthesis in human skin fibroblasts and rat aortic smooth muscle cells exposed to lipoprotein-depleted serum and high density apolipoprotein/phospholipid mixtures. Biochim Biophys Acta. 1976;431:347-358.
5. Picardo M, Massey JB, Kuhn DE, Gotto AM Jr, Gianturco SH, Pownall HJ. Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts. Arteriosclerosis 1986;6:434-441.
6. Kawano M, Miida T, Fielding CJ, Fielding PE. Quantitation of pre§-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry. 1993;32:5025-5028.
7. Hayek T, Oiknine J, Brook JG, Aviram M. Role of apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice. Biochem Biophys Res Commun. 1994;205:1072-1078.
8. Duverger N, Ghalim N, Ailhaud G, Steinmetz A, Fruchart JC, Castro G. Characterization of ApoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb. 1993;13: 126-132.
9. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR. Apolipoprotein AI-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res. 1993;34:317-324.
10. Clay MA, Newnham HH, Forte TM, Barter PJ. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apoA-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1992;1124:52-58.
11. Nichols AV, Gong EL, Blanche PJ, Forte TM. HDL populations: origins and interconversions. In: Miller NE. ed. High Density Lipoproteins and Atherosclerosis II. Amsterdam. Netherlands: Excerpta Medica; 1989: 159-171.
12. Basu PK, Brown MS, Ho YK, Havel RJ, Goldstein JL. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci U S A. 1981;78:7545-7549.
13. Forte TM, Krauss RM, Lindgren FT, Nichols AV. Changes in plasma lipoprotein distribution and formation of two unusual particles after heparin-induced lipolysis in hypertriglyceridemic subjects. Proc Natl Acad Sci U S A. 1979;76:5934-5938.
14. Green PHR, Tall AR, Glickman RM. Rat intestine secretes discoid high density lipoprotein. J Clin Invest. 1978;61:528-534.
15. Norum KR, Gjone E, Glomset JA. Familial lecithin:cholesterol acyltransferase deficiency, including fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill; 1989:1181-1193.
16. Lerch PG, Morgenthaler JJ, Peitsch MC, Friedli H, Hodler G, Doran JE, Isliker H, Heiniger HJ. Isolation and properties of apolipoprotein A for therapeutic use. In: Poulik MD, ed. Protides of the Biological Fluids. Proceedings of the 36th Colloquium. Vol 36. Lipoproteins, IgG and IgA subclasses, cytofluorometry. New York, NY: Pergamon Press; 1989: 409-416.
17. Lerch PG, Förtsch V, Hodler G, Bolli R. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications. Vox Sang. 1996;71:155-164.
18. Forte TM, Nordhansen RW. Electron microscopy of negatively stained lipoproteins. Methods Enzymol. 1986;128:442-457.
19. Lerch PG, Moudry R, Doran JE, Hubsch A, Omar A, Morgenthaler JJ, Isliker H, Heiniger HJ. In vitro characteristics of reconstituted HDL for therapy. Proceedings of European Lipoprotein Club. Bruges, Belgium: European Lipoprotein Club; 1992; Abstract.
20. Nanjee MN, Miller NE. Sequential microenzymatic assay of cholesterol, triglycerides, and phospholipids in a single aliquot. Clin Chem. 1996;42: 915-926.
21. Demacker PNM, Hijmans AGM, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem. 1980;26:1775-1779.
22. Nanjee MN, Crouse JR, King JM, Hovorka R, Rees SE, Carson ER, Morgenthaler JJ, Lerch P, Miller NE. Effects of intravenous infusion of lipid-free apoA-I in humans. Arterioscler Thromb Vasc Biol. 1996;16: 1203-1214.
23. Nanjee MN, Miller NE. Effects of intravenous apolipoprotein A-I/ phosphatidylcholine discs in humans. Circulation. 1996;94:1-463. Abstract.
24. Johnson FL, Babiak J, Rudel LL. High density lipoprotein accumulation in perfusates of isolated livers of African green monkeys. Effects of saturated versus polyunsaturated dietary fat. J Lipid Res. 1986;27: 537-548.
25. Cheung MC, Lum KD, Brouillette CG, Bisgaier CL. Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res. 1989;30:1429-1436.
26. Magill P, Rao SN, Miller NE, Nicoll A, Brunzell J, St Hilaire J, Lewis B. Relationships between the metabolism of high-density and very-low-density lipoproteins in men: studies of apolipoprotein kinetics and lipoprotein lipase activity. Eur J Clin Invest. 1982;12:113-120.
27. Shepherd J, Packard CJ, Gotto AM Jr, Taunton OD. Comparison of two methods to investigate the metabolism of human apolipoproteins A-I and A-II. J Lipid Res. 1978;19:656-661.
28. Gylling H, Vega GL, Grundy SM. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res. 1992;33:1527-1539.
29. Brinton EA, Eisenberg S, Breslow JL. Increased apoA-I, and apoA-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991; 87:536-544.
30. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982;23:850-862.
31. Malmendier CL, Delcroix C, Ameryckx JP. In vivo metabolism of human apoprotein A-I-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-I metabolism. Clin Chim Acta. 1983; 131:201-210.
32. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
33. Bruce C, Davidson WS, Kussie P, Lund-Katz S, Phillips MC, Ghosh R, Tall AR. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins. J Biol Chem. 1995;270: 11532-11542.
34. Brown MS, Goldstein JL. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest. 1983;72:743-747.
35. Windler E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985;26:556-565.
36. Edelstein C, Halari M, Scanu AM. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. J Biol Chem. 1982;257:7189-7195.
37. Miita T, Kawano M, Fielding CJ, Fielding PE. Regulation of the concentration of pre§ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry. 1992;31:11112-11117.
38. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res. 1992;33:1807-1816.
39. Ishida BY, Albee D, Paigen B. Interconversion of prebeta-migrating lipoproteins containing apolipoprotein A-I and HDL. J Lipid Res. 1990; 31:227-236.
40. Nichols AV, Blanche PJ, Gong EL, Shore VG, Forte TM. Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase. Biochim Biophys Acta. 1985;834:285-300.
41. Nichols AV, Gong EL, Blanche PJ, Forte TM, Shore VG. Pathways in the formation of human plasma high density lipoprotein subpopulations containing apolipoprotein A-I without apolipoprotein A-II. J Lipid Res. 1987;28:719-732.
42. 2b (d 1.063-1.100 g/ml) with single-bilayer liposomes of dimyristoylphosphatidylcholine. Lipids. 1978;13:943-950.
43. Horowitz BS, Goldberg IJ, Merab J, Vanni T, Ramakrishnan R, Ginsberg HN. Role of the kidney in increased clearance of apolipoprotein A-I in subjects with reduced high density lipoprotein cholesterol concentrations. In: Miller NE, Tall AR, eds. High Density Lipoproteins and Atherosclerosis III. Amsterdam, Netherlands: Excerpta Medica: 1992;215-222.
44. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Regulation of pre-beta high density lipoproteins in human tissue fluids in vivo. Circulation. 1997;96:1-662. Abstract.
45. Clay MA, Newnham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler Thromb. 1991;11: 415-422.
46. Liang HQ, Rye KA, Barter PJ. The dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J Lipid Res. 1994;35: 1187-1199.
47. Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like particles and reduction of cellular cholesterol. J Biol Chem. 1991;266:3080-3086.
48. Clay MA, Barter PJ. Formation of new HDL particles from lipid-free apolipoprotein A-I. J Lipid Res. 1996;37:1722-1732.
49. Carlson LA. Effect of a single infusion of recombinant human proapolipoprotein A-I liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol. Nutr Metab Cardiovasc Dis. 1995;5:85-91.
50. Kuivenhoven JA, Demacker PNM, Stalenhoef AFH, Pajkrt D, van Deventer SJH, Doran JE, Pritchard H, Kastelein JJP. Infusion of reconstituted HDL: reverse cholesterol transport in hereditary HDL deficiencies. Circulation. 1996;94:I-343. Abstract.
51. Aviram M, Williams KJ, McIntosh RA, Carpentier YA, Tall AR, Deckelbaum RJ. Intralipid infusion abolishes ability of human serum to cholesterol-load cultured macrophages. Arteriosclerosis. 1989;9:67-75.
52. Taskinen MR, Nikkilä EA, Kuusi T, Tulikoura I. Changes of high density lipoprotein subfraction concentration and composition by Intralipid in vivo and by lipolysis of Intralipid in vitro. Arteriosclerosis. 1983;3:607-615.
53. Neary R, Bhatnagar D, Durrington P, Ishola M, Arrol S, Mackness M. An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins. Atherosclerosis. 1991;89:35-48.
54. Koizumi J, Kano M, Okabayashi K, Jadhav A, Thompson GR. Behavior of human apolipoprotein A-I: phospholipid and apo HDL: phospholipid complexes in vitro and after injection into rabbits. J Lipid Res. 1988;29: 1405-1415.
55. Rodrigueza WV, Mazany KD, Essenburg AD, Pape ME, Rea TJ, Bisgaier CL, Williams KJ. Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Arterioscler Thromb Vasc Biol. 1997;17:2132-2139.
56. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem. 1996;271:2023-2028.
57. Rodrigueza WV, Williams KJ, Rothblat GH, Phillips MC. Remodelling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler Thromb Vasc Biol. 1997;17:383-393.
58. Mendez AJ. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res. 1997;38:1807-1821.